DIN 02387727 — MYLAN-NEVIRAPINE 200 MG
MYLAN-NEVIRAPINE is a tablet of Nevirapine marketed by MYLAN PHARMACEUTICALS ULC. The full Nevirapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02387727
- Brand name
- MYLAN-NEVIRAPINE
- Active ingredient
- Nevirapine
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Health Canada status
- MARKETED
- Drug class
- Non-nucleoside reverse transcriptase inhibitor (antiretroviral)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nevirapine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02318601 | AURO-NEVIRAPINE | 200 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02405776 | JAMP NEVIRAPINE | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |